Pfizer

Tucson, Arizona

Oncologygene therapyPhase IIIListed · PFE

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

What changed

Phase I trial registered: A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

1w agoTrial registeredJul 9, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
Study registered
Jun 1, 2027
Breast Neoplasms · NOT_YET_RECRUITING · sponsor: Pfizer · Korea Post Marketing Surveillance (PMS) Study of Talzenna®
ClinicalTrials.gov · NCT04982848 (opens the source filing in a new tab)
Trial
PHASE2 registered
May 28, 2026
Colitis, Ulcerative · RECRUITING · sponsor: Pfizer · A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
ClinicalTrials.gov · NCT07470879 (opens the source filing in a new tab)
Trial
PHASE3 registered
May 11, 2026
Respiratory Syncytial Virus (RSV) · RECRUITING · sponsor: Pfizer · A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
ClinicalTrials.gov · NCT07543380 (opens the source filing in a new tab)
Trial
PHASE1 registered
Apr 13, 2026
Healthy · NOT_YET_RECRUITING · sponsor: Pfizer · A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults
ClinicalTrials.gov · NCT07235163 (opens the source filing in a new tab)
Trial
PHASE1 registered
Feb 4, 2026
Overweight, Obesity, Healthy · ACTIVE_NOT_RECRUITING · sponsor: Pfizer · A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
ClinicalTrials.gov · NCT07400679 (opens the source filing in a new tab)
Trial
PHASE2/PHASE3 registered
Oct 3, 2025
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma · RECRUITING · sponsor: Pfizer · A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ClinicalTrials.gov · NCT06989437 (opens the source filing in a new tab)
Trial
PHASE1 registered
Aug 26, 2025
Healthy Adults · COMPLETED · sponsor: Pfizer · A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144
ClinicalTrials.gov · NCT07636018 (opens the source filing in a new tab)
Trial
PHASE1 registered
Aug 14, 2025
Healthy Participant · COMPLETED · sponsor: Pfizer · A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants
ClinicalTrials.gov · NCT07130097 (opens the source filing in a new tab)
Trial
PHASE3 registered
Apr 1, 2025
Alopecia Areata · ACTIVE_NOT_RECRUITING · sponsor: Pfizer · A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
ClinicalTrials.gov · NCT06873945 (opens the source filing in a new tab)
Trial
PHASE1 registered
Dec 23, 2024
Healthy · COMPLETED · sponsor: Pfizer · A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.
ClinicalTrials.gov · NCT06541678 (opens the source filing in a new tab)
Trial
PHASE1 registered
Dec 11, 2024
Healthy · COMPLETED · sponsor: Pfizer · A Study to Learn if the Study Medicine Called Itraconazole and if Food Changes How the Body Processes the Other Study Medicine Called PF 07258669 in Older Adults or Healthy Adults
ClinicalTrials.gov · NCT06706869 (opens the source filing in a new tab)
Trial
Study registered
Aug 19, 2024
Breast Cancer · COMPLETED · sponsor: Pfizer · A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)
ClinicalTrials.gov · NCT05912933 (opens the source filing in a new tab)
Trial
PHASE2 registered
Jul 30, 2024
Pneumococcal Disease · COMPLETED · sponsor: Pfizer · A Study to Learn About How a New Pneumococcal Vaccine Works in Children
ClinicalTrials.gov · NCT06531538 (opens the source filing in a new tab)
Trial
Study registered
Mar 1, 2024
Alopecia Areata · ACTIVE_NOT_RECRUITING · sponsor: Pfizer · Litfulo Capsules Special Investigation
ClinicalTrials.gov · NCT06279221 (opens the source filing in a new tab)
Trial
PHASE1 registered
Feb 1, 2024
Healthy Volunteers · COMPLETED · sponsor: Pfizer · A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
ClinicalTrials.gov · NCT06172348 (opens the source filing in a new tab)
Trial
PHASE3 registered
Nov 29, 2023
Migraine · COMPLETED · sponsor: Pfizer · A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
ClinicalTrials.gov · NCT05989048 (opens the source filing in a new tab)
Trial
PHASE1 registered
Nov 3, 2023
Respiratory Syncytial Virus Infection · COMPLETED · sponsor: Pfizer · A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
ClinicalTrials.gov · NCT05987072 (opens the source filing in a new tab)
Trial
PHASE1 registered
Mar 17, 2023
Healthy · COMPLETED · sponsor: Pfizer · A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.
ClinicalTrials.gov · NCT05767905 (opens the source filing in a new tab)
Trial
Study registered
Aug 17, 2022
Household Contacts · TERMINATED · sponsor: Pfizer · A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.
ClinicalTrials.gov · NCT04543357 (opens the source filing in a new tab)
Trial
PHASE3 registered
May 30, 2022
Sickle Cell Disease, Leg Ulcers · TERMINATED · sponsor: Pfizer · Resolution of Sickle Cell Leg Ulcers With Voxelotor
ClinicalTrials.gov · NCT05561140 (opens the source filing in a new tab)
Trial
PHASE2 registered
Jan 13, 2022
Esophagitis · TERMINATED · sponsor: Pfizer · Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
ClinicalTrials.gov · NCT04821310 (opens the source filing in a new tab)
Trial
Study registered
Jul 15, 2021
Metastatic Breast Cancer · COMPLETED · sponsor: Pfizer · Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
ClinicalTrials.gov · NCT04937660 (opens the source filing in a new tab)
Trial
Study registered
Dec 14, 2020
Neoplasms, Embolism · ACTIVE_NOT_RECRUITING · sponsor: Pfizer · Anticoagulation in Patients With Venous Thromboembolism and Cancer
ClinicalTrials.gov · NCT04618913 (opens the source filing in a new tab)
Trial
Study registered
Oct 21, 2019
Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis · COMPLETED · sponsor: Pfizer · Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
ClinicalTrials.gov · NCT03885089 (opens the source filing in a new tab)
Trial
Study registered
Oct 3, 2019
Transthyretin (TTR) Amyloid Cardiomyopathy · COMPLETED · sponsor: Pfizer · Vyndaqel Capsules Special Investigation (ATTR-CM)
ClinicalTrials.gov · NCT04108091 (opens the source filing in a new tab)
Trial
PHASE2 registered
May 24, 2019
Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor, Rhabdomyosarcoma, Neuroblastoma, Medulloblastoma, Diffuse Intrinsic Pontine Glioma · ACTIVE_NOT_RECRUITING · sponsor: Pfizer · Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
ClinicalTrials.gov · NCT03709680 (opens the source filing in a new tab)
Trial
PHASE1 registered
Apr 17, 2018
Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL) · RECRUITING · sponsor: Pfizer · A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
ClinicalTrials.gov · NCT03460977 (opens the source filing in a new tab)
Trial
Study registered
Jun 4, 2015
Rheumatoid Arthritis · COMPLETED · sponsor: Pfizer · To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.
ClinicalTrials.gov · NCT05576051 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.95{"reasons":["name similarity 100%","shared principal investigator / founder","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 0.73{"reasons":["name similarity 100%","shared principal investigator / founder","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 0.73{"reasons":["name similarity 100%","shared principal investigator / founder","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 0.73{"reasons":["name similarity 100%","shared principal investigator / founder","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 0.73{"reasons":["name similarity 100%","shared principal investigator / founder","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 0.73{"reasons":["name similarity 100%","shared principal investigator / founder","same therapeutic area"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
new_entity links the trial record at 0.24{"reasons":["same therapeutic area"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Phase I trial registered: A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
1w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
1w agoTrial recruitingSource (opens the source filing in a new tab)
Phase III trial registered: A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
1w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
1w agoTrial recruitingSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
1w agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)
2w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)
2w agoTrial completedSource (opens the source filing in a new tab)
Phase II trial registered: A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
3w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
3w agoTrial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
4w agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
5w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
5w agoTrial completedSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144
5w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144
5w agoTrial completedSource (opens the source filing in a new tab)
Phase III trial registered: A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
6w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
6w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Anticoagulation in Patients With Venous Thromboembolism and Cancer
7w agoTrial registeredSource (opens the source filing in a new tab)
Phase III trial registered: A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
8w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
8w agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Vyndaqel Capsules Special Investigation (ATTR-CM)
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Vyndaqel Capsules Special Investigation (ATTR-CM)
2mo agoTrial completedSource (opens the source filing in a new tab)
Phase III trial registered: A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
2mo agoTrial registeredSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants
2mo agoTrial completedSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults
4mo agoTrial registeredSource (opens the source filing in a new tab)
Phase II trial registered: A Study to Learn About How a New Pneumococcal Vaccine Works in Children
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn About How a New Pneumococcal Vaccine Works in Children
4mo agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Litfulo Capsules Special Investigation
4mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.
6mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.
6mo agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Korea Post Marketing Surveillance (PMS) Study of Talzenna®
8mo agoTrial registeredSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Learn if the Study Medicine Called Itraconazole and if Food Changes How the Body Processes the Other Study Medicine Called PF 07258669 in Older Adults or Healthy Adults
11mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn if the Study Medicine Called Itraconazole and if Food Changes How the Body Processes the Other Study Medicine Called PF 07258669 in Older Adults or Healthy Adults
11mo agoTrial completedSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.
11mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.
11mo agoTrial completedSource (opens the source filing in a new tab)
Phase III trial registered: Resolution of Sickle Cell Leg Ulcers With Voxelotor
Jul 2025Trial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
Jun 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
Jun 2025Trial completedSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.
Jun 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.
Jun 2025Trial completedSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
Apr 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
Apr 2025Trial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Phase I trial registered: A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
Feb 2025Trial completedSource (opens the source filing in a new tab)
Phase II trial registered: Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Jan 2025Trial registeredSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

Study registered

PHASE2 registered

PHASE3 registered

PHASE1 registered

PHASE1 registered

PHASE2/PHASE3 registered

PHASE1 registered

PHASE1 registered

PHASE3 registered

PHASE1 registered

PHASE1 registered

Study registered

PHASE2 registered

Study registered

PHASE1 registered

PHASE3 registered

PHASE1 registered

PHASE1 registered

Study registered

PHASE3 registered

PHASE2 registered

Study registered

Study registered

Study registered

Study registered

PHASE2 registered

PHASE1 registered

Study registered